Home・Stock List・Zoetis Inc

Zoetis Inc

Closed

SectorHealthcare

75.98 -1.43

Buy Sell

Overview

Share price change

24h

Current

Min

76.83

Max

79.78

Key metrics
By Trading Economics
Income	-2M 601M
Sales	-125M 2.3B
P/E Sector Avg	12.61 64.641
EPS	1.53
Dividend yield	2.69
Profit margin	26.569
Employees	14,500
EBITDA	-8M 939M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+28.58% upside

Dividends
By Acuity
Dividend yield Sector Avg	2.69% 2.31%
Next Earnings	6 Aug 2026
Next Dividend date	1 Sept 2026
Next Ex Dividend date	30 Oct 2026

Market Stats
By TradingEconomics
Market Cap	-16B 32B
Previous open	77.41
Previous close	75.98

News Sentiment

By Acuity

43%

57%

135 / 340 Healthcare

Zoetis Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 Aug 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 Jul 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 Jul 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 Jul 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 Jul 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 Jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 Jul 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 Jul 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 Jul 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 Jul 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 Jul 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 Jul 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

28.58% upside

12 Months Forecast

Average 99.38 USD 28.58%

High 130 USD

Low 85 USD

Based on 12 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Zoetis Inc - Dist in the past 3 months.

Sentiment

By Acuity

135 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.